Ibrutinib and Rituximab Provides Superior Clinical Outcome Compared to FCR in Younger Patients with Chronic Lymphocytic Leukemia (CLL): Extended Follow-up from the E1912 TrialTait D. Shanafelt,Victoria Wang,Neil E. Kay,Curtis A. Hanson,Susan M. O'Brien,Jacqueline C. Barrientos,Diane F. Jelinek,Esteban Braggio,Jose F. Leis, Cong Christina Zhang,Steven Coutre,Paul M. Barr,Amanda F. Cashen,Anthony R. Mato,Avina Singh,Michael P. Mullane,Richard F. Little,Harry P. Erba,Richard M. Stone,Mark Litzow,Martin S. TallmanBlood（2019）引用 55|浏览92暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
